India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat COVID-19 patients with moderate to severe acute respiratory...
from NDTV News - Topstories https://ift.tt/3iU2Gg6
Subscribe to:
Post Comments (Atom)
India central to EY’s AI strategy: Truncale
from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/pV5Z0oc
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
-
Meng Wanzhou, the high-profile top executive of telecom giant Huawei who was detained in Canada for over three years, received a hero's ...
No comments:
Post a Comment